The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saverino, D.
Right arrow Articles by Ciccone, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saverino, D.
Right arrow Articles by Ciccone, E.
The Journal of Immunology, 1999, 162: 651-658.
Copyright © 1999 by The American Association of Immunologists

CTLA-4 (CD152) Inhibits the Specific Lysis Mediated by Human Cytolytic T Lymphocytes in a Clonally Distributed Fashion1

Daniele Saverino*, Claudya Tenca*, Daniela Zarcone*, Andrea Merlo{ddagger}, Anna M. Megiovanni{ddagger}, Maria T. Valle{ddagger}, Fabrizio Manca{ddagger}, Carlo E. Grossi*,{dagger} and Ermanno Ciccone2,{dagger}

* Department of Experimental Medicine, Institute of Human Anatomy, University of Genova, Genova, Italy; {dagger} National Institute for Cancer Research; {ddagger} Advanced Biotechnology Center, Department of Immunology, S. Martino Hospital, Genova, Italy

Since the functional outcome of effector T lymphocytes depends on a balance between activatory and inhibitory receptors, we studied the ability of CTLA-4 (CD152) to inhibit the cytolytic function of CTL. In 22 TCR{alpha}ß+CD3+8+ CTL clones, activation induced by anti-CD3, anti-CD28, or anti-CD2 mAb was inhibited by anti-CD152 mAb in a redirected killing assay. In eight clones inhibition was >40%, in 10 it ranged between 20–40%, and in four it was <20%. This suggests the existence of a clonal heterogeneity as well as for the ability of CTLA-4 to inhibit CD3/TCR-, CD28-, or CD2-mediated CTL activation. To support further this contention, we used an experimental model based upon Ag-specific CTL. Eight Ag-specific T cell clones that lyse autologous EBV-infected B lymphocytes, but are unable to lyse allogeneic EBV-infected B cell lines, were used in a cytolytic assay in which anti-CD152 mAb or soluble recombinant receptor (i.e., CTLA-4 Ig) were included. In this system, at variance from the redirected killing assay, cross-linking of surface molecules by mAb does not occur. Thus, addition of anti-CD152 mAb or of CTLA-4 Ig and anti-CD80/CD86 mAb to the assay should result in a blockade of receptor/ligand interactions. As a consequence, inhibition of a negative signal, such as that delivered via CD152, should enhance lysis. A >40% increment of target cell lysis was achieved in three of eight clones studied. Since it is not equally shared by all CTL clones, this feature also appears to be clonally distributed.




This article has been cited by other articles:


Home page
 J. Virol.Home page
D. Homann, W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, and M. G. von Herrath
Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity
J. Virol., January 1, 2006; 80(1): 270 - 280.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Saudemont and B. Quesnel
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis
Blood, October 1, 2004; 104(7): 2124 - 2133.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Deaglio, M. Zubiaur, A. Gregorini, F. Bottarel, C. M. Ausiello, U. Dianzani, J. Sancho, and F. Malavasi
Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells
Blood, April 1, 2002; 99(7): 2490 - 2498.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Saverino, A. Merlo, S. Bruno, V. Pistoia, C. E. Grossi, and E. Ciccone
Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells
J. Immunol., January 1, 2002; 168(1): 207 - 215.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Merlo, D. Saverino, C. Tenca, C. E. Grossi, S. Bruno, and E. Ciccone
CD85/LIR-1/ILT2 and CD152 (Cytotoxic T Lymphocyte Antigen 4) Inhibitory Molecules Down-Regulate the Cytolytic Activity of Human CD4+ T-Cell Clones Specific for Mycobacterium tuberculosis
Infect. Immun., October 1, 2001; 69(10): 6022 - 6029.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Saverino, M. Fabbi, F. Ghiotto, A. Merlo, S. Bruno, D. Zarcone, C. Tenca, M. Tiso, G. Santoro, G. Anastasi, et al.
The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions
J. Immunol., October 1, 2000; 165(7): 3742 - 3755.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Bruno, M. Fabbi, M. Tiso, B. Santamaria, F. Ghiotto, D. Saverino, C. Tenca, D. Zarcone, S. Ferrini, E. Ciccone, et al.
Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis
Carcinogenesis, May 1, 2000; 21(5): 893 - 900.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. D. Griffin, D. K. Hong, P. O. Holman, K.-M. Lee, M. J. Whitters, S. M. O'Herrin, F. Fallarino, M. Collins, D. M. Segal, T. F. Gajewski, et al.
Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)
J. Immunol., May 1, 2000; 164(9): 4433 - 4442.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.